The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice
Open accessAbstract
Histone deacetylase (HDAC) inhibitors show remarkable therapeutic potential for a variety of disorders, including cancer, neurological disease, and cardiac hypertrophy. However, the specific HDAC isoforms that mediate their actions are unclear, as are the physiological and pathological functions of individual HDACs in vivo. To explore the role of Hdac3 in the heart, we generated mice with a conditional Hdac3 null allele. Although global deletion of Hdac3 resulted in lethality by E9.5, mice with a cardiac-specific deletion of Hdac3 survived until 3-4 months of age. At this time, they showed massive cardiac hypertrophy and upregulation of genes associated with fatty acid uptake, fatty acid oxidation, and electron transport/oxidative phosphorylation accompanied by fatty acid-induced myocardial lipid accumulation and elevated triglyceride levels. These abnormalities in cardiac metabolism can be attributed to excessive activity of the nuclear receptor PPARalpha. The phenotype associated with cardiac-specific Hdac3 gene deletion differs from that of all other Hdac gene mutations. These findings reveal a unique role for Hdac3 in maintenance of cardiac function and regulation of myocardial energy metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Self-citationPeroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., Richardson, J. A., & Olson, E. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608791103 · Cited by 1,507
Self-citationCardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Self-citationDuvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025999 · Cited by 1,141
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065
Self-citationSignal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Self-citationClass II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Self-citationPrognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension
Devereux, R. B. (2004) · JAMA · doi:10.1001/jama.292.19.2350 · Cited by 881
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 1×
“Class II HDACs act as antihypertrophic mediators through the binding and repression of MEF2 and other transcription factors in the adult heart (10–11); however, class II HDACs do not possess intrinsic deacetylase activity but instead recruit the NCoR/SMRT-Hdac3 complex to mediate deacetylation and transcriptional repr…”
BackgroundHistone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility
Montgomery, R. L., Davis, C. A., Potthoff, M. J., Haberland, M., Fielitz, J., Qi, X., Hill, J. A., Richardson, J. A., & Olson, E. N. (2007) · Genes & Development · doi:10.1101/gad.1563807 · Cited by 712
Self-citationThe SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3
Guenther, M. G., Barak, O., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6091-6101.2001 · Cited by 611
Agah, R., Frenkel, P. A., French, B. A., Michael, L. H., Overbeek, P. A., & Schneider, M. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119509 · Cited by 606
Gui, C.-Y., Ngo, L., Xu, W. S., Richon, V. M., & Marks, P. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307708100 · Cited by 550
Grozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537
Sakai, K., & Miyazaki, J.-I. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7111 · Cited by 493
Huss, J. M., Torra, I. P., Staels, B., Giguère, V., & Kelly, D. P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9079-9091.2004 · Cited by 485
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480 · cited 1×
“tion is coupled to a decreased utilization of the glucose oxidation pathway (26).”
BackgroundNuclear Receptor Signaling and Cardiac Energetics
Huss, J. M., & Kelly, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000141774.29937.e3 · Cited by 473
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., Floss, T., Goettlicher, M., Noppinger, P. R., Wurst, W., et al. (2007) · Nature Medicine · doi:10.1038/nm1552 · Cited by 468
Cheng, L., Ding, G., Qin, Q., Huang, Y., Lewis, W., He, N., Evans, R. M., Schneider, M. D., Brako, F. A., Xiao, Y., et al. (2004) · Nature Medicine · doi:10.1038/nm1116 · Cited by 453
Sizing up the heart: development redux in disease
Olson, E. N., & Schneider, M. D. (2003) · Genes & Development · doi:10.1101/gad.1110103 · Cited by 385
Self-citationSuppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy
Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B. A., Olson, E. N., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.625467 · Cited by 377
Self-citationKee, H. J., Sohn, I. S., Nam, K. I., Park, J. E., Qian, Y. R., Yin, Z., Ahn, Y., Jeong, M. H., Bang, Y.-J., Kim, N., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.559724 · Cited by 368
Watanabe, K., Fujii, H., Takahashi, T., Kodama, M., Aizawa, Y., Ohta, Y., Ono, T., Hasegawa, G., Naito, M., Nakajima, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000248200 · Cited by 314
Corepressors selectively control the transcriptional activity of PPARγ in adipocytes
Guan, H.-P., Ishizuka, T., Chui, P. C., Lehrke, M., & Lazar, M. A. (2005) · Genes & Development · doi:10.1101/gad.1263305 · Cited by 293
Toward transcriptional therapies for the failing heart: chemical screens to modulate genes
McKinsey, T. A., & Olson, E. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524144 · Cited by 288
Self-citationNuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart
Burkart, E. M., Sambandam, N., Han, X., Gross, R. W., Courtois, M., Gierasch, C. M., Shoghi, K., Welch, M. J., & Kelly, D. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32578 · Cited by 279
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Knutson, S. K., Chyla, B. J., Amann, J. M., Bhaskara, S., Huppert, S. S., & Hiebert, S. W. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.51 · Cited by 271
Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors
Antos, C. L., McKinsey, T. A., Dreitz, M., Hollingsworth, L. M., Zhang, C.-L., Schreiber, K., Rindt, H., Gorczynski, R. J., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303113200 · Cited by 269
Self-citationThe Retinoblastoma-Histone Deacetylase 3 Complex Inhibits PPARγ and Adipocyte Differentiation
Fajas, L., Egler, V., Reiter, R., Hansen, J., Kristiansen, K., Debril, M.-B., Miard, S., & Auwerx, J. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00360-x · Cited by 258
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice
Kim, Y., Phan, D., van Rooij, E., Wang, D.-Z., McAnally, J., Qi, X., Richardson, J. A., Hill, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33255 · Cited by 249
Self-citationFast chromatin immunoprecipitation assay
Nelson, J. D. (2006) · Nucleic Acids Research · doi:10.1093/nar/gnj004 · Cited by 235
Cocco, T., Di, M., Papa, P., & Lorusso, M. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00034-9 · Cited by 228
YOUNG, M. E., PATIL, S., YING, J., DEPRE, C., SINGH AHUJA, H., SHIPLEY, G. L., STEPKOWSKI, S. M., DAVIES, P. J. A., & TAEGTMEYER, H. (2001) · The FASEB Journal · doi:10.1096/fj.00-0351com · Cited by 223
Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2
Grégoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., & Yang, X.-J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00882-06 · Cited by 203 · cited 1×
“Additionally, Hdac3 has been shown to directly bind and deacetylate MEF2, thereby regulating MEF2 activity (43).”
BackgroundMitochondrial Uncoupling: A Key Contributor to Reduced Cardiac Efficiency in Diabetes
Boudina, S., & Abel, E. D. (2006) · Physiology · doi:10.1152/physiol.00008.2006 · Cited by 199 · cited 2×
“Increased fatty acid oxidation results in increased reducing equivalents to the electron transport chain, which in turn generates free radicals and leads to mitochondrial uncoupling (30).”
BackgroundCardiac histone acetylation – therapeutic opportunities abound
McKinsey, T. A., & Olson, E. N. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.02.002 · Cited by 142
Self-citationDavis, C. A., Haberland, M., Arnold, M., Sutherland, L. B., McDonald, O. G., Richardson, J. A., Childs, G. J., Harris, S., Owens, G. K., & Olson, E. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2626-2636.2006 · Cited by 131
Self-citationLeft Ventricular Hypertrophy: The Next Treatable, Silent Killer?
Gardin, J. M., & Lauer, M. S. (2004) · JAMA · doi:10.1001/jama.292.19.2396 · Cited by 111
Rotenone-like Action of the Branched-chain Phytanic Acid Induces Oxidative Stress in Mitochondria
Schönfeld, P., & Reiser, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513198200 · Cited by 109
Prognostic significance of left ventricular mass change during treatment of hypertension
Devereux, R. B., Wachtell, K., & Gerdts, E. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.043 · Cited by 96
LOSKOVICH, M. V., Grivennikova, V. G., Cecchini, G., & Vinogradov, A. D. (2005) · Biochemical Journal · doi:10.1042/bj20041703 · Cited by 75
Accumulation of Myocardial Triglycerides in Ketotic Diabetes: Evidence for Increased Biosynthesis
Murthy, V. K., & Shipp, J. C. (1977) · Diabetes · doi:10.2337/diab.26.3.222 · Cited by 73
Yu, X., Tesiram, Y. A., Towner, R. A., Abbott, A., Patterson, E. S., Huang, S., Garrett, M. W., Chandrasekaran, S., Matsuzaki, S., Szweda, L. I., et al. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-6 · Cited by 70
Self-citationGlyn-Jones, S., Song, S., Black, M. A., Phillips, A. R. J., Choong, S. Y., & Cooper, G. J. S. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00204.2006 · Cited by 47
Villagra, A., Natalia Ulloa, M., Zhang, X. M., Yuan, Z., Sotomayor, E. M., & Seto, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701719200 · Cited by 38
Okin, P. M., Devereux, R. B., & Jern, S. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.044 · Cited by 20
Cited by
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
Self-citationHistone Deacetylase Inhibitors as Anticancer Drugs
Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071414 · Cited by 1,206
The world of protein acetylation
Drazic, A., Myklebust, L. M., Ree, R., & Arnesen, T. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.007 · Cited by 804
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 663
(2011) · PubMed Central · Cited by 560
Metadata
- Authors
- Montgomery, R. L., Potthoff, M. J., Haberland, M., Qi, X., Matsuzaki, S., Humphries, K. M., Richardson, J. A., Bassel-Duby, R., & Olson, E. N.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-11-03
- Volume
- 118
- Issue
- 11
- Pages
- 3588-3597
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2026694991
- Cited by
- 362
- References
- 55
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.